Skip to main content

Table 1 Number of deaths and patients at risk for every consecutive 2-month period as extracted from digitized survival curves (see appendix for details)

From: Network meta-analysis of survival data with fractional polynomials

Study 1 Study 2 Study 3 Study 4 Study 5 Study 6 Study 7
Lee et al., 2010 Chang et al. 2006 Kim et al., 2008 Maruyama et al., 2008 Hanna et al., 2004 Cufer et al., 2006 Shepherd et al., 2000
Gefitinib Docetaxel BSC Gefitinib Gefitinib Docetaxel Gefitinib Docetaxel Pemtrexed Docetaxel Gefitinib Docetaxel BSC Docetaxel
r n r n r N r n r n r n r n r n r n r n r n r n r n r n
7 81 9 76 22 107 34 235 98 723 73 710 18 245 9 244 27 283 33 288 11 68 14 73 17 222 49 441
5 74 4 67 24 85 35 201 104 625 109 637 30 226 21 233 47 256 48 255 8 57 11 59 71 205 67 392
7 69 8 64 11 61 29 166 94 518 102 503 25 197 23 214 31 209 41 207 5 49 6 48 53 134 60 325
6 62 5 56 8 50 15 137 79 424 66 401 22 169 15 189 33 178 21 166 14 44 6 42 70 160 63 340
6 55 8 51 12 42 11 122 64 336 68 339 12 148 23 173 40 144 34 144 9 31 7 36 12 90 49 277
3 49 4 38 6 30 14 110 46 272 41 271 18 127 17 140 17 78 17 78 4 21 4 29 22 78 14 228
4 46 6 34 1 24 1 97 35 225 32 228 10 98 9 105 21 61 13 61 8 18      55 221
3 42 2 28      30 190 29 196 8 77 10 87 8 40 18 48        41 166
3 38 4 26      14 131 18 139 6 63 15 69 11 33 9 30        30 125
3 35 3 22      14 117 16 121 4 47 4 44    10 21         
5 29 3 18      14 83 13 89 3 35 5 35             
4 24 2 15      8 69 10 76 1 29 3 25             
3 21 1 13      5 50 6 46 1 25 2 18             
1 18 1 12      3 45 5 40 2 18 1 14             
3 17 2 10      6 31 4 24    1 10             
3 14 2 8        3 20                 
1 12